Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Genentech licenses Xenova's OX40/OX40 ligand technology

April 24, 2002

Go-ahead received for group A Streptococcus vaccine trial

April 17, 2002

AMD-3100 evaluated in healthy volunteers in combination with Neupogen

April 16, 2002

Product R to enter phase II as topical treatment for genital warts

April 16, 2002

HE-2200 for potentiating impaired immune systems

April 15, 2002

Oxxon Pharmaccines licenses MVA technology from Alpharma

April 12, 2002

Roche to codevelop ISAtx-247 with Isotechnika

April 11, 2002

Rhein Biotech licenses RC-529 for use in hepatitis B vaccines

April 11, 2002

Sankyo presents new immunosuppressants in recent patent

April 10, 2002

Berna Biotech and Iomai collaborate to develop transdermal patch vaccines

April 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...